Best Practices in Counseling Multiple Myeloma Patients on Therapeutic Options

Video Library —July 13, 2020
Charise Gleason, MSN, NP-BC, AOCNP
Advanced Practice Provider Chief, Winship Cancer Institute,
Emory University,
Atlanta, GA
Chelsea Sprouse, RN-BSN, MSN, NP-C
Nurse Practitioner, Inpatient and Outpatient Malignant Hematology,
Levine Cancer Institute,
Charlotte, NC
Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma, and PGY2 Oncology Residency Research Coordinator,
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA

Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, provide their perspectives on how to counsel patients on the best frontline treatment options for newly-diagnosed MM, and how this differs from relapsed/refractory MM, where individualizing treatment plans based on the patient needs and tolerability of treatment is key.

Related Articles
Patient Support Services in Multiple Myeloma
Charise Gleason, MSN, NP-BC, AOCNP, Chelsea Sprouse, RN-BSN, MSN, NP-C, Kathryn Maples, PharmD, BCOP
|
Video Library
Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, discuss their personal experiences with patient support groups for multiple myeloma patients that deal with pharmacy issues, financial problems, management of pain and neuropathy, psychological and nutritional support.
Oral Therapies for Multiple Myeloma
Charise Gleason, MSN, NP-BC, AOCNP, Chelsea Sprouse, RN-BSN, MSN, NP-C, Kathryn Maples, PharmD, BCOP
|
Video Library
Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, share their experiences with complex treatment regimens that include oral therapy, especially as it relates to patients’ appropriate adherence to therapy.
Moving Multiple Myeloma Treatment from IV Infusions to SQ Injections
Charise Gleason, MSN, NP-BC, AOCNP, Chelsea Sprouse, RN-BSN, MSN, NP-C, Kathryn Maples, PharmD, BCOP
|
Video Library
Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C, discuss their perspectives on using SQ treatments for MM, including the benefits for the patients, along with a requirement for education and training for nurses with respect to delivering a high volume injection into the SQ space.
Last modified: July 15, 2020

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code